UK markets closed
NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
83.37 +0.68 (+0.82%) GOLD FUTURES
2,399.20 +10.80 (+0.45%) DOW
37,803.86 +50.55 (+0.13%) Bitcoin GBP
50,987.16 +2,543.22 (+5.25%)
Theravance Biopharma, Inc. (TBPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:52PM EDT. Market open.
| Previous close | 9.52 |
| Open | 9.51 |
| Bid | 9.36 x 100 |
| Ask | 9.49 x 100 |
| Day's range | 9.35 - 9.52 |
| 52-week range | 8.21 - 11.98 |
| Volume | |
| Avg. volume | 364,543 |
| Market cap | 456.95M |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Zacks
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.